Observation of Therapy With Micardis® (Telmisartan) in Patients With Essential Hypertension in Hospitals

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02238262

Enrollment

2318

Registered

2014-09-12

Start date

2000-05-31

Completion date

Unknown

Last updated

2014-09-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Brief summary

The aim of the observational study was to supplement the data on efficacy, safety and tolerability of telmisartan under daily conditions in hospitals

Interventions

DRUGTelmisartan

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patients with diagnosis of essential hypertension * Minimum age of 18 years

Exclusion criteria

* NA

Design outcomes

Primary

Measure	Time frame
Change in clinic blood pressure	up to 14 days
Number of patients with adverse drug reactions	up to 14 days

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026